Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Interleukin-2
The First People's Hospital of Lianyungang
Beta Thalassemia Major
1 trial -
Intraoperative Radiation Therapy in Malignant Cerebral Tumor
The First People's Hospital of Lianyungang
Glioblastoma
1 trial -
Intrauterine lavage therapy
The First People's Hospital of Lianyungang
Intrauterine Adhesions
1 trial -
Intravenous Anesthetic Induction with Ciprofol for Painless Colonoscopy in Elderly Patients
The First People's Hospital of Lianyungang
Ciprofol
1 trial -
Irinotecan Hydrochloride Liposome Injection；Carboplatin Injection；Serplulimab Injection
The First People's Hospital of Lianyungang
Small Cell Lung Cancer
1 trial -
Iron sucrose, Human Erythropoietin Injection, Vitamin C
The First People's Hospital of Lianyungang
Anemia
1 trial -
Ivarmacitinib tablet
The First People's Hospital of Lianyungang
Polymyalgia Rheumatics (PMR)
1 trial -
Kava (Piper methysticum) extract
The First People's Hospital of Lianyungang
Sleep
1 trial -
Ketamine
The First People's Hospital of Lianyungang
Intensive Care Unit
1 trial -
Kunxian capsule
The First People's Hospital of Lianyungang
Diabetic Nephropathy
1 trial -
Lactated ringers solution
The First People's Hospital of Lianyungang
Pancreatitis, Chronic
1 trial -
Lactulose
The First People's Hospital of Lianyungang
Colon Disease
1 trial -
Latanoprost
The First People's Hospital of Lianyungang
Ocular Hypertension
1 trial -
Lenalidomide
The First People's Hospital of Lianyungang
Diffuse Large B Cell Lymphoma
1 trial -
Letrozole
The First People's Hospital of Lianyungang
Intrauterine Insemination
1 trial -
Leuprorelin acetate + Sintilimab
The First People's Hospital of Lianyungang
NSCLC, Stage III
1 trial -
Levofloxacin
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
3 trials -
Lidocaine
The First People's Hospital of Lianyungang
Heart Failure
1 trial -
Liquid Biopsy Early Screening
The First People's Hospital of Lianyungang
Liquid Biopsy for Early Screening of Lung Cancer
1 trial -
Liraglutide
The First People's Hospital of Lianyungang
Ischemic Stroke
1 trial -
Luspatercept
The First People's Hospital of Lianyungang
Transfusion-dependent Non-severe Aplastic Anemia
1 trial -
MTBF regimen
The First People's Hospital of Lianyungang
Relapse Leukemia
1 trial -
Medical Management
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Medical Treatment
The First People's Hospital of Lianyungang
Basilar Artery Occlusion
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources